2012 Press Releases

• B. Braun Introduces Next Generation Safety-Engineered Catheter
  Bethlehem, PA — April 26, 2012 — B. Braun Medical Inc. (B. Braun) will attend INS 2012 with their latest development in safety-engineered medical devices, the Introcan Safety^® 3 Closed IV Catheter. The new product includes the proven passive protection from needlestick injuries that has made B. Braun the U.S. leader in passive safety-engineered IV catheters. Advancements in the new Introcan Safety^® 3's design include the unique multi-access blood control septum to protect healthcare professionals from blood exposure and an integrated stabilization platform that helps to improve catheter stability and minimize movement within the vessel. "Recent research confirms passive safety engineered devices are most effective for needlestick injury prevention," said Tom Sutton, Vice President, Vascular Access and IV Systems for B. Braun Medical Inc. "The Introcan Safety^® 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control septum to aid in the prevention of blood exposure each time the device is accessed."
  more >>

• Connecting Safety and Drug Administration: B. Braun Announces addEASE^® BC2000
  Bethlehem, PA — March 26, 2012 — B. Braun Medical Inc. introduced its modified 20mm addEASE^® BC2000 Binary Connector to bring additional ease-of-use to pharmacy technicians and nurses responsible for mixing, activating and administering drug admixtures. Designed for exclusive use with B. Braun's PAB^® Partial Additive Bags, the redesigned BC2000 can be assembled in an ISO Class 5 environment, provides a safe, accurate means of admixing medications in the pharmacy and on the nursing floor, and is not manufactured with potentially harmful DEHP phthalates.
  more >>

• B. Braun Employee Giving Supports Make-a-Wish
  Bethlehem, PA — February 27, 2012 — B. Braun Medical Inc. (B. Braun) was recognized by the Make-A-Wish Foundation^® on February 27th for donations valuing over $21,000. It was the second year since Make-A-Wish was selected as the Foundation to be supported by a campaign that is annually integrated into the company's National Sales Meeting. Cash and airline mile donations from the three-hundred-thirty meeting attendees were matched by the company so that the wishes of six children from the Lehigh Valley can be granted. This year's campaign produced a 62% increase over 2011.
  more >>

• Needlestick Safety Remains Top Concern for Healthcare Professionals in the New Year
  Bethlehem, PA — February 7, 2012 — Despite legislation and continued focus across the U.S. to improve sharps safety, needlestick injuries (NSIs) resulting in the exposure to infectious disease continue to be a major issue facing all healthcare professionals. Lynn Hadaway, M.Ed., RN, BC, CRNI, who has more than 35 years experience in infusion nursing and adult education, addressed this topic during a B. Braun Medical Inc. (B. Braun) showcase session held during the Association for Vascular Access (AVA) 2011 Annual Scientific Meeting in San Jose, Calif.
  more >>

• B. Braun Becomes the First to Deliver FDA-Approved 2G Cefazolin
  Bethlehem, PA — January 23, 2012 — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it received U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX^® Drug Delivery System.
  more >>